电子加速器生产医用同位素钼-99的发展现状与展望

Development Status and Prospect for the Medical Isotope Molybdenum-99 Produced by Electron Accelerator

  • 摘要: 99Mo的衰变子体99mTc是核医学领域中应用最广泛的放射性同位素,近年全球主要的99Mo生产堆面临着非计划检修及关停退役等问题,导致其供应不稳定,因此多个发达国家已在积极开发99Mo生产的替代性技术。本文介绍了多种利用粒子加速器代替反应堆生产99Mo的技术路线,总结了电子加速器生产99Mo的国内外研究进展,详细论述了加速器性能指标和照射装置与靶件设计、99mTc分离提取、100Mo回收利用以及废物管理等关键技术,为国内有关技术的基础、应用研究与电子加速器生产99Mo的商业化提出建议。

     

    Abstract: As the decay daughter of 99Mo, 99mTc is the most widely used radioisotope in the field of nuclear medicine. Recently, the major 99Mo production reactors in the world are facing problems such as unplanned maintenance, shutdown and decommission, resulting in the unstable supply of 99Mo. Therefore, many developed countries have been actively exploiting alternative technologies for 99Mo production. In this paper, various 99Mo-production technologies by particle accelerator instead of reactor were introduced, and the research progress of producing 99Mo based on electron accelerator was summarized at home and abroad. The accelerator performance index and the key technologies in the production process were discussed in detail, such as the design of irradiation device and target, separation of 99mTc, recovery of 100Mo and waste management. In addition, some suggestions were put forward for the basic and applied research of relevant technologies in China and the commercialization of 99Mo production by electron accelerator.

     

/

返回文章
返回